These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17462391)

  • 1. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes.
    Kress DC; Aronson S; McDonald ML; Malik MI; Divgi AB; Tector AJ; Downey FX; Anderson AJ; Stone M; Clancy C
    Ann Thorac Surg; 2007 May; 83(5):1737-43. PubMed ID: 17462391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.
    Bennett-Guerrero E; Slaughter TF; White WD; Welsby IJ; Greenberg CS; El-Moalem H; Ortel TL
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1567-72. PubMed ID: 16308000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
    Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM
    Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia.
    Welsby IJ; Um J; Milano CA; Ortel TL; Arepally G
    Anesth Analg; 2010 Jan; 110(1):30-5. PubMed ID: 19933539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
    Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
    Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support.
    Schenk S; El-Banayosy A; Prohaska W; Arusoglu L; Morshuis M; Koester-Eiserfunke W; Kizner L; Murray E; Eichler P; Koerfer R; Greinacher A
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1373-81.e4. PubMed ID: 16733172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
    Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
    Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
    Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
    Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
    Gettings EM; Brush KA; Van Cott EM; Hurford WE
    Crit Care; 2006; 10(6):R161. PubMed ID: 17109753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
    Matsuo T; Tomaru T; Kario K; Hirokawa T;
    Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
    Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome.
    Kuitunen A; Suojaranta-Ylinen R; Raivio P; Kukkonen S; Lassila R
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):18-22. PubMed ID: 17289474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.
    Demir M; Duran E; Yigitbasi O; Vural O; Kurum T; Yuksel M; Turgut B; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):279-84. PubMed ID: 17636189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.
    Williams RT; Damaraju LV; Mascelli MA; Barnathan ES; Califf RM; Simoons ML; Deliargyris EN; Sane DC
    Circulation; 2003 May; 107(18):2307-12. PubMed ID: 12707235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.